Therefore, we further validated the effectiveness of hormonal therapy in the treatment of uterine leiomyoma and ERK1/ERK2 might serve as a therapeutic target from the perspectives of snRNA-seq and ST. This evidence concerns the gene MAPK3 and uterine corpus leiomyoma.